Literature DB >> 6789989

Cephaloridine encephalopathy.

R Taylor, R Arze, R Gokal, J C Stoddart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789989      PMCID: PMC1506590          DOI: 10.1136/bmj.283.6288.409

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Penetration of cephalothin into the spinal fluid.

Authors:  N J Vianna; D Kaye
Journal:  Am J Med Sci       Date:  1967-08       Impact factor: 2.378

2.  Neurotoxicity and "massive" intravenous therapy with penicillin. A study of possible predisposing factors.

Authors:  H Smith; P I Lerner; L Weinstein
Journal:  Arch Intern Med       Date:  1967-07

3.  Toxicity, distribution, and excretion of cephaloridine in laboratory animals.

Authors:  J S Welles; W R Gibson; P N Harris; P M Small; R C Anderson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

4.  Penicillin-induced encephalopathy in uremic patients.

Authors:  H A Bloomer; L J Barton; R K Maddock
Journal:  JAMA       Date:  1967-04-10       Impact factor: 56.272

5.  Convulsion following intrathecal cephaloridine.

Authors:  H Yoshioka; H Nambu; M Fujita; H Uehara
Journal:  Infection       Date:  1975       Impact factor: 3.553

  5 in total
  2 in total

Review 1.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Tolerance in patients with terminal renal insufficiency of high doses of cefotaxime.

Authors:  D Höffler; T Wittgens; C Piper
Journal:  Infection       Date:  1985       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.